Xilio Therapeutics (XLO)
Develops masked immuno-oncology therapies designed to activate within tumors.
$8.94
vs last close−0.10 (−1.11%)
Something off on this page? Send us feedback.
Next report
Nov 5, 26
estimated · in 43 days
EPS estimate
−$0.82
Revenue estimate
$4.8M
Fiscal quarter
Q3 FY26
EPSReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported−$2.80−$2.52−$2.24−$1.54−$0.85−$0.58−$0.33Pending
Estimate−$3.08−$0.11−$1.12−$0.42−$1.68−$0.66−$0.59−$0.82
Surprise+9.1%−2,190.9%−100.0%−266.7%+49.4%+12.1%+44.1%—
RevenueReportedEstimate
Mar '25May '25Aug '25Nov '25Mar '26May '26Aug '26Nov '26
Reported$1.7M$2.9M$8.1M$19.1M$13.7M$12.7M$18.7MPending
Estimate$3.3M$4.4M$8.2M$18.6M$10.9M$8.5M$12.7M$4.8M
Surprise−47.8%−33.8%−1.5%+2.3%+25.6%+48.5%+46.9%—
HistoryUpcoming
| Date / Period | Estimate | Reported | Surprise |
|---|---|---|---|
| Dec 2027 | −$0.78 | — | — |
| Sep 2027 | −$0.03 | — | — |
| Jun 2027 | −$0.73 | — | — |
| Mar 2027 | −$0.70 | — | — |
| Dec 2026 | −$0.85 | — | — |
| Nov 2026 | −$0.82 | — | — |
| Aug 2026 | −$0.59 | −$0.33 | +44.1% |
| May 2026 | −$0.66 | −$0.58 | +12.1% |
| Mar 2026 | −$1.68 | −$0.85 | +49.4% |
| Nov 2025 | −$0.42 | −$1.54 | −266.7% |
| Aug 2025 | |||
| May 2025 | |||
| Mar 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Apr 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Mar 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| May 2022 | |||
| Mar 2022 | |||
| Dec 2021 | |||
| Jun 2021 | |||
| Mar 2021 | |||
| Dec 2020 | |||
| Sep 2020 | |||
| Jun 2020 | |||
| Mar 2020 |
| Date / Period | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise | Reaction |
|---|---|---|---|---|---|---|---|
| Dec 2027 | −$0.78 | — | — | $2.3M | — | — | — |
| Sep 2027 | −$0.03 | — | — | $17.6M | — | — | — |
| Jun 2027 | −$0.73 | — | — | $3.1M | — | — | — |
| Mar 2027 | −$0.70 | — | — | $3.6M | — | — | — |
| Dec 2026 | −$0.85 | — | — | $4.2M | — | — | — |
| Nov 5, 2026 | −$0.82 | — | — | $4.8M | — | — | — |
| Aug 13, 2026 | −$0.59 | −$0.33 | +44.1% | $12.7M | $18.7M | +46.9% | −0.4% |
| May 12, 2026 | −$0.66 | −$0.58 | +12.1% | $8.5M | $12.7M | +48.5% | 0.0% |
| Mar 23, 2026 | −$1.68 | −$0.85 | +49.4% | $10.9M | $13.7M | +25.6% | 0.0% |
| Nov 13, 2025 | −$0.42 | −$1.54 | −266.7% | $18.6M | $19.1M | +2.3% | −9.3% |
| Aug 14, 2025 | |||||||
| May 8, 2025 | |||||||
| Mar 11, 2025 | |||||||
| Nov 7, 2024 | |||||||
| Aug 8, 2024 | |||||||
| May 14, 2024 | |||||||
| Apr 1, 2024 | |||||||
| Nov 9, 2023 | |||||||
| Aug 14, 2023 | |||||||
| May 9, 2023 | |||||||
| Mar 2, 2023 | |||||||
| Nov 9, 2022 | |||||||
| Aug 9, 2022 | |||||||
| May 12, 2022 | |||||||
| Mar 1, 2022 | |||||||
| Dec 2, 2021 | |||||||
| Jun 30, 2021 | |||||||
| Mar 31, 2021 | |||||||
| Dec 31, 2020 | |||||||
| Sep 30, 2020 | |||||||
| Jun 30, 2020 | |||||||
| Mar 31, 2020 |